Nonpartisan civic infrastructure
AllCiv·Legis1
·

H.R. 311

BillFederalHouseIn Committee
To provide for quality assurance of COVID-19 reimbursements and reporting.
About This Bill
Committee
Latest Action · March 5, 2021
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Congress
117th (2021–2023)
Introduced
January 13, 2021
Cosponsors (0)
None
View PDF ↗

Summary

Highlight any text to annotate
This bill (1) establishes documentation requirements for testing, treatment, and reporting related to COVID-19 (i.e., coronavirus disease 2019); and (2) makes it unlawful to knowingly report a false diagnosis of COVID-19. To receive a federal reimbursement for the cost of a COVID-19 diagnostic test or treatment, the request for reimbursement must document that the administered COVID-19 test has been approved, cleared, or authorized by the Food and Drug Administration. Further, the Centers for Disease Control and Prevention must exclude from its official COVID-19 case and death counts any person who tested positive and requested federal reimbursement without the required documentation. Additionally, any person who knowingly reports a false diagnosis of COVID-19 is subject to criminal fines and imprisonment for not more than 10 years.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.